All treatments
Treatment
ZYN002 Transdermal Gel Cannabidiol (CBD) clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
An Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of ZYN002 Administered as a Transdermal Gel to Children, Adolescents and Young Adults with Fragile X Syndrome
This study looks at the long-term safety of a CBD gel for children, teenagers, and young adults with Fragile X Syndrome. It also checks if the gel helps with common symptoms like irritability and social difficulties over time.
For: Fragile X Syndrome (FXS)Ireland - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children, Adolescents, and Young Adults with Fragile X Syndrome - RECONNECT
This study is testing a CBD gel called ZYN002 for people with Fragile X syndrome. It aims to see if the gel can help with social avoidance and other behaviours in children, teenagers, and young adults.
For: Fragile X syndrome (FXS)Ireland